Dr. Tomoki Otani is business development lead of Logomix, a synthetic biology company enabling MB-scale genomic engineering in mammalian cells. Combining careers in research science and a top-tier management consulting firm, McKinsey & Company, Tomoki’s expertise spans from stem cell biology, ophthalmology and genomic engineering to business growth strategy and drug launch excellence.